Winton Group’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-53,035
| Closed | -$564K | – | 851 |
|
|
2023
Q2 | $564K | Sell |
53,035
-203,619
| -79% | -$2.17M | 0.05% | 274 |
|
|
2023
Q1 | $2.7M | Buy |
256,654
+57,514
| +29% | +$605K | 0.16% | 140 |
|
|
2022
Q4 | $2.47M | Buy |
199,140
+19,165
| +11% | +$237K | 0.16% | 157 |
|
|
2022
Q3 | $1.87M | Buy |
179,975
+67,976
| +61% | +$704K | 0.12% | 217 |
|
|
2022
Q2 | $1.29M | Buy |
+111,999
| New | +$1.29M | 0.07% | 405 |
|
|
2021
Q4 | – | Sell |
-71,214
| Closed | -$930K | – | 1205 |
|
|
2021
Q3 | $930K | Sell |
71,214
-21,428
| -23% | -$280K | 0.05% | 539 |
|
|
2021
Q2 | $1.19M | Buy |
92,642
+14,189
| +18% | +$183K | 0.06% | 430 |
|
|
2021
Q1 | $877K | Sell |
78,453
-12,204
| -13% | -$136K | 0.05% | 542 |
|
|
2020
Q4 | $1.03M | Sell |
90,657
-194,651
| -68% | -$2.22M | 0.07% | 398 |
|
|
2020
Q3 | $2.57M | Sell |
285,308
-20,285
| -7% | -$182K | 0.08% | 414 |
|
|
2020
Q2 | $3.15M | Buy |
305,593
+274,576
| +885% | +$2.83M | 0.08% | 427 |
|
|
2020
Q1 | $313K | Buy |
+31,017
| New | +$313K | 0.01% | 1161 |
|